ArticleDrug design, development and therapy2021

The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study.

Wenli Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.